These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23362274)

  • 1. Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus.
    Hendricks GL; Weirich KL; Viswanathan K; Li J; Shriver ZH; Ashour J; Ploegh HL; Kurt-Jones EA; Fygenson DK; Finberg RW; Comolli JC; Wang JP
    J Biol Chem; 2013 Mar; 288(12):8061-8073. PubMed ID: 23362274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses.
    Hendricks GL; Velazquez L; Pham S; Qaisar N; Delaney JC; Viswanathan K; Albers L; Comolli JC; Shriver Z; Knipe DM; Kurt-Jones EA; Fygenson DK; Trevejo JM; Wang JP; Finberg RW
    Antiviral Res; 2015 Apr; 116():34-44. PubMed ID: 25637710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gel-capture assay for characterizing the sialyl-glycan selectivity of influenza viruses.
    Velkov T; Thompson PE; El-Kabbani O; Lindh F; Stambas J; Rockman S
    Acta Virol; 2011; 55(2):131-7. PubMed ID: 21692561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo.
    Bhatia S; Lauster D; Bardua M; Ludwig K; Angioletti-Uberti S; Popp N; Hoffmann U; Paulus F; Budt M; Stadtmüller M; Wolff T; Hamann A; Böttcher C; Herrmann A; Haag R
    Biomaterials; 2017 Sep; 138():22-34. PubMed ID: 28550754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
    Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
    Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of potent sialidase-based inhibitors of influenza virus replication.
    von Itzstein M; Wu WY; Kok GB; Pegg MS; Dyason JC; Jin B; Van Phan T; Smythe ML; White HF; Oliver SW
    Nature; 1993 Jun; 363(6428):418-23. PubMed ID: 8502295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection.
    Komatsu T; Kido N; Sugiyama T; Yokochi T
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):1-7. PubMed ID: 22856509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
    Sriwilaijaroen N; Wilairat P; Hiramatsu H; Takahashi T; Suzuki T; Ito M; Ito Y; Tashiro M; Suzuki Y
    Virol J; 2009 Aug; 6():124. PubMed ID: 19678928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.
    McKimm-Breschkin JL; Blick TJ; Sahasrabudhe A; Tiong T; Marshall D; Hart GJ; Bethell RC; Penn CR
    Antimicrob Agents Chemother; 1996 Jan; 40(1):40-6. PubMed ID: 8787876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virucidal nano-perforator of viral membrane trapping viral RNAs in the endosome.
    Kong B; Moon S; Kim Y; Heo P; Jung Y; Yu SH; Chung J; Ban C; Kim YH; Kim P; Hwang BJ; Chung WJ; Shin YK; Seong BL; Kweon DH
    Nat Commun; 2019 Jan; 10(1):185. PubMed ID: 30643128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
    Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY
    Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
    Mendel DB; Tai CY; Escarpe PA; Li W; Sidwell RW; Huffman JH; Sweet C; Jakeman KJ; Merson J; Lacy SA; Lew W; Williams MA; Zhang L; Chen MS; Bischofberger N; Kim CU
    Antimicrob Agents Chemother; 1998 Mar; 42(3):640-6. PubMed ID: 9517945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
    Leneva IA; Goloubeva O; Fenton RJ; Tisdale M; Webster RG
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1216-24. PubMed ID: 11257037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.
    Suzuki T; Takahashi T; Guo CT; Hidari KI; Miyamoto D; Goto H; Kawaoka Y; Suzuki Y
    J Virol; 2005 Sep; 79(18):11705-15. PubMed ID: 16140748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
    Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
    Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialyllactose-Modified Three-Way Junction DNA as Binding Inhibitor of Influenza Virus Hemagglutinin.
    Yamabe M; Kaihatsu K; Ebara Y
    Bioconjug Chem; 2018 May; 29(5):1490-1494. PubMed ID: 29566328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.